FDA NDC Directory · JSON-LD · Markdown

Bivalirudin

NDC 63323-562 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA090189
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBIVALIRUDIN (250 mg/1)
Marketing started20161028
Package count1

External sources

Source: openFDA. Public-domain (CC0).